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INTRODUCTION
The classification of canine lymphoid malignancies into groups based on cell of origin
(B- or T-cell types) is possible with immunophenotypic analysis. A high frequency of
B-cell lymphomas has been described; about 30% of lymphomas are of T-cell origin
(Teske et al., 1994a; Fournel-Fleury et al., 1997; Grindem et al., 1998). In human
medicine the major diagnostic role of blood lymphocyte subset typing is the screening
for non-Hodgkin’s lymphomas with peripheral blood involvement and their
differentation from reactive lymphoproliferative conditions (Thalhammer-Scherrer
et al., 2000). The aim of this project is to evaluate the diagnostic efficacy of blood
immunophenotyping in dogs with lymphoma in order to detect the blood involve-
ment and the prognostic benefits.
MATERIALS ANDMETHODS
Forty-eight dogs, 32 males and 16 females, ranging from 3 to 14 years old, of varying
breeds, were examined. The diagnosis of lymphoma was performed on cytological
smears. The immunophenotype was detected from lymph node cellular suspensions
or cavity fluids using flow cytometry (FACScan Becton Dickinson): 36 cases were
CD21+ B-cell, 7 were CD4+ T-cell, 3 were CD8+ T-cell and 2 were CD4−CD8−
T-cell lymphomas. A complete blood count and a phenotypic analysis of blood
lymphocyte subpopulations were performed. The following monoclonal antibodies,
specific for canine leukocyte antigens, were used: CD21 (CA2.1D6), IgG F(ab∞)2 and
IgM, CD5 (DH3B), CD3 (CA17.2A12), CD4 (CA13.1E4), CD8 (CA9.JD3), CD45RA
(CA4.1D3), CD49d (CA4.5B3) and CD45 (CA12.10C12). Except for CD5 (VMRD,
Pulmann, Washington, USA) and IgG, IgM (Jackson Immunoresearch, West Grove,
PA, USA), all monoclonal antibodies were kindly provided by Dr P.F. Moore (U.C.
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Davies, CA, USA). The results were compared to reference values of a control goup
of 50 healthy dogs (Guglielmino et al., 1995).
RESULTS
In agreement with Jain (1993), the complete blood count showed a mild to modest
anaemia in 46% of the dogs, thrombocytopenia in 44% and mild (18,300/ml ) to
extreme (342,000/ml ) leukocytosis in 33%. Only 19% of cases exhibited lymphocyto-
sis; lymphoblasts were present for 12 dogs (25%), and 15%were without lymphocyto-
sis. In 10% of cases leukopenia was observed and lymphopenia was observed in 25%
of cases. Five out of 36 (14%) B-cell lymphomas showed CD21+ B-cell lymphocytosis
(ranging from 5520 to 115,670/ml ); four cases showed a moderate increase of B lym-
phocytes without lymphocytosis. A CD8+ T-cell increase was observed in seven B-cell
lymphomas. This is also noted for human patients with neoplastic disorders, where
an increase in the so-called ‘anti-tumour’ cytolytic CD8+ T lymphocytes occurs
(Quaglino et al., 1993). Two out of seven CD4+ T-cell lymphomas showed lympho-
cytosis (17,680 and 45,050/ml ) with an increase in CD4+ T lymphocytes. Five dogs
(71%) exhibited an increased CD4/CD8 ratio: in three cases this was due to an
absolute increase in CD4+ T cells. One dog showed an abnormal immunophenotype
(TCD4+CD45− ) both in the lymph node and in the peripheral blood. In two out of
the three dogs with CD8+ T-cell lymphoma a mild increase in the absolute count of
CD8+ T lymphocytes, without lymphocytosis, was noted; one of these showed the
same abnormal immunophenotype as the lymph node (TCD8+CD45− ). Extreme
lymphocytosis (12,690 and 338,580/ml ), due to neoplastic cells, was observed for two
dogs with CD4−CD8− T-cell lymphoma.
DISCUSSION
In dogs with lymphoma the total and differential leukocyte counts and the presence
of atypical lymphocytes were very variable: indeed blood involvement was not always
detectable on a simple complete blood count. The detection of neoplastic cells (5
T-cell and 4 B-cell lymphomas) with the same immunophenotype as the origin
tumours, also without lymphocytosis and cells with atypical morphology, was pos-
sible using flow cytometric analysis of peripheral blood. The immunophenotype of
the peripheral blood was able to provide more precise information about systemic
involvement. In 75% (9/12) of T-cell lymphomas and in 25% (9/36) of B-cell lympho-
mas a systemic involvement was present, confirming a poorer prognosis for T-cell
lymphomas as compared with B-cell lymphomas (Teske et al., 1994b). Simultaneous
immunophenotyping of blood, lymph node and bone marrow from dogs with lym-
phoma could represent an important diagnostic and prognostic tool. Our study
supports the potential use of blood immunophenotyping as a sensitive tool in the
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detection of leukaemic cells, facilitation of tumour staging and monitoring of
remission or relapse.
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